• PT Youtube
  • PT Facebook
  • PT Linkedin
  • PT Twitter
3/24/2020 | 1 MINUTE READ

Reifenhauser Converts Lab Lines to Produce Face Masks

Facebook Share Icon LinkedIn Share Icon Twitter Share Icon Share by EMail icon Print Icon

Will operate four-shift operation 24/7 till further notice. Says it will produce enough material to make 1 million face masks a day.

Reifenhauser has converted two of its R&D lines at its nonwovens technology center in Troisdorf, Germany to full-production system for making meltblown material for face masks.

In a press released issued by the company, it said the two meltblown lines will be operated in four-shift operation 24/7, which it says will produce enough PP material to make 1 million face masks a day. Trial operations will be almost completely suspended during this period. Said Michael Maas, who is responsible for the Reifenhauser nonwoven test plant: “Due to the corona pandemic, the customer visits and tests that were actually planned have increasingly been cancelled, so that plant capacities and personnel capacities have been freed up anyway. Switching the plant from test to production operation therefore makes double sense.”

Reifenhauser Converts Lab Lines to Face-Mask Production

The meltblown material from the nonwoven technology center is already
sold out for the next five weeks. However, Reifenhäuser says it continues
to look for opportunities to strengthen the local supply during this crisis.
The company is in close contact with associations, authorities and other
companies, according to the release.

Added Dr. Bernd Kunze, CEO of Reifenhäuser Reicofil: “We have considered what contribution we can make in this crisis. This is of course mainly the fast delivery of meltblown lines to build up additional capacities. We have drastically reduced our delivery times here. But we also wanted to provide support at shorter notice. Until the currently lacking capacities are built up, we are therefore stepping in with the test plants in our pilot plant station. Not using this capacity now would be irresponsible in our view.”

Manufacturing response to COVID-19 pandemic.

RELATED CONTENT